×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Genmab: Epcoritamab combo shows high response in R/R DLBCL patients eligible for ASCT
U.S. FDA Approves Ziihera® (zanidatamab-hrii), With or Without Tislelizumab Plus Chemotherapy, for the First-Line Treatment of HER2-Positive Advanced Gastroesophageal Adenocarcinoma
25 Aug 2026
Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved two
...
Elysium Therapeutics to Discuss Fentanyl Rebound and Synthetic Opioid Rescue Drug
Virax Biolabs CEO James Foster Updates Shareholders Following the Fiscal 2026 Annual Report and Commercial Supply Agreement with Fosun Diagnostics
Zai Lab Reports High Response Rates, Encouraging Durability, and a Favorable Safety Profile for Zocilurtatug Pelitecan (Zoci; Formerly ZL-1310) in First-Line Extensive-Stage Small Cell Lung Cancer
Avanzanite Announces an Exclusive Agreement to License and Market Zemcelpro® in Europe
Swisslog Healthcare Launches the Allegro Refrigeration Module and Expands Its Tenutō Cold Chain and Connected Pharmacy Platform
By
Swisslog Healthcare
Swisslog Healthcare
19 Nov 2026
Immorta Bio Demonstrates That SenoMune™-0257-Stimulated T Cells Can Perform “Serial Killing” of Senescent Cells
By
Immorta Bio, Inc
Immorta Bio, Inc
20 Nov 2026
Sonic Incytes Announces a Multi-Year Partnership with Madrigal Pharmaceuticals to Advance Non-Invasive Liver Assessment for MASH
By
Sonic Incytes Medical Corp
Sonic Incytes Medical Corp
20 Nov 2026
Phase 3 Results for XTORO® (Finafloxacin Otic Suspension), 0.3%, in Acute Otitis Externa Published in the Annals of Otology, Rhinology & Laryngology
By
Fonseca Biosciences
Fonseca Biosciences
18 Nov 2026
Thermo Fisher Scientific Launched Gibco™ VaxEvo™ CD 293 Medium to Advance the Production of Adenovirus Vaccines
By
Thermo Fisher
Thermo Fisher
18 Nov 2026
As Employers Face Rising GLP-1 Costs, Looking Beyond Price Becomes Essential
By
US-Rx
US-Rx
17 Nov 2026
Most Popular
Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride for Injection in the U.S
By
Glenmark Pharmaceuticals Ltd
Apr 03
Ascletis announces completion of enrollment in its U.S. Phase II study evaluating ASC30, an oral small-molecule GLP-1R agonist, for diabetes treatment
By
Ascletis Pharma Inc.
Apr 27
Blue Earth Therapeutics shares positive Phase 1 results for Lutetium (177Lu) rhPSMA-10.1 Injection, advancing its clinical development
By
Blue Earth Therapeutics Ltd
Oct 08
November
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand